FMO5 and epilepsy: We also demonstrated that inhibiting NADPH oxidase with AEBSF, an irreversible serine protease inhibitor, which undoubtedly has some other off‐target effects, similarly neuroprotects and prevents the development of epilepsy following status epilepticus in rats (Figure 3).27, 37